A new monoclonal antibody for detecting degalactosylated IgA1 as serum biomarker of IgA nephropathy

Nephrology Dialysis Transplantation

Volumn 30, Issue 8, 2015, Pages 1234-1236

  Coppo, Rosanna ^a  

^a CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE LINKED OLIGOSACCHARIDE; AUTOANTIBODY; DEGALACTOSYLATED IMMUNOGLOBULIN A1; GALACTOSE DEFICIENT IMMUNOGLOBULIN A1; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A1; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; GALACTOSE; LECTIN;

ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL PROLIFERATION; DISEASE ACTIVITY; DISEASE COURSE; DISEASE MARKER; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; MESANGIUM CELL; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR; SENSITIVITY AND SPECIFICITY; ANIMAL; BLOOD; DEFICIENCY; FEMALE; GLOMERULONEPHRITIS, IGA; GLOMERULUS; METABOLISM; PATHOLOGY;

ANIMALS; BIOMARKERS; FEMALE; GALACTOSE; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN A; KIDNEY GLOMERULUS; LECTINS;

EID: 84939638316     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfv234     Document Type: Article

References (26)

1. Berger J, Hinglais N. Les dépôts intercapillaires d'IgA-IgG (intercapillary deposits of IgA-IgG). J Urol Nephrol 1968; 74: 694-695
2. Conley ME, Cooper MD, Michael AF. Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus. J Clin Invest 1980; 66: 1432-1436
3. Allen AC, Bailey EM, Brenchley PE et al. Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation. Observations in three patients. Kidney Int 2001; 60: 969-973
4. Hiki Y, Odani H, Takahashi M et al. Mass spectrometry proves under-Oglycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int 2001; 59: 1077-1085
5. Baenziger J, Kornfeld S. Structure of the carbohydrate units of IgA1 immunoglobulin II. Structure of the O-glycosidically linked oligosaccharide units. J Biol Chem 1974; 249: 7270-7281
6. Allen AC, Harper SJ, Feehally J. Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin Exp Immunol 1995; 100: 470-474
7. Mestecky J, Tomana M, Crowley-Nowick PA et al. Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy. Contrib Nephrol 1993; 104: 172-182
8. Hiki Y, Tanaka A, Kokubo T et al. Analyses of IgA1 hinge glycopeptides in IgA nephropathy by matrix-assisted laser desorption/ionization time-offlight mass spectrometry. J Am Soc Nephrol 1998; 9: 577-582
9. Novak J, Julian BA, Mestecky J et al. Glycosylation of IgA1 and pathogenesis of IgA nephropathy. Semin Immunopathol 2012; 34: 365-382
10. Peruzzi L,Amore A, Cirina P et al. Integrin expression and IgA nephropathy: in vitro modulation by IgA with altered glycosylation and macromolecular IgA. Kidney Int 2000; 58: 2331-2340
11. Coppo R, Amore A. Aberrant glycosylation in IgA nephropathy (IgAN). Kidney Int 2004; 65: 1544-1547
12. Amore A, Conti G, Cirina P et al. Aberrantly glycosylated IgA molecules downregulate the synthesis and secretion of vascular endothelial growth factor in human mesangial cells. Am J Kidney Dis 2000; 36: 1242-1252
13. Camilla R, Suzuki H, Daprà V et al. Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy. Clin J AmSoc Nephrol 2011; 6: 1903-1911
14. Coppo R, Fonsato V, Balegno S et al. Aberrantly glycosylated IgA1 induces mesangial cells to produce platelet-activating factor that mediates nephrin loss in cultured podocytes. Kidney Int 2010; 77: 417-427
15. Moldoveanu Z, Wyatt RJ, Lee JY et al. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int 2007; 71: 1148-1154
16. Gharavi AG, Moldoveanu Z, Wyatt RJ et al. Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J Am Soc Nephrol 2008; 19: 1008-1014
17. Gharavi AG, Kiryluk K, ChoiMet al. Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat Genet 2011; 43: 321-327
18. Kiryluk K, Li Y, Scolari F et al. Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens. Nat Genet 2014; 46: 1187-1196
19. Suzuki H, Kiryluk K, Novak J et al. The pathophysiology of IgA nephropathy. J Am Soc Nephrol 2011; 22: 1795-1803
20. Suzuki H, Fan R, Zhang Z et al. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest 2009; 119: 1668-1677
21. Gómez-Guerrero C, Duque N, Egido J. Mesangial cells possess an asialoglycoprotein receptor with affinity for human immunoglobulin A. J Am Soc Nephrol 1998; 9: 568-576
22. Berthoux F, Suzuki H, Thibaudin L et al. Autoantibodies targeting galactose- deficient IgA1 associated with progression of IgA nephropathy. J Am Soc Nephrol 2012; 23: 1579-1587
23. Suzuki H, Moldoveanu Z, Hall S et al. IgA nephropathy: characterization of IgG antibodies specific for galactose-deficient IgA1. Contrib Nephrol 2007; 157: 129-133
24. Suzuki Y, Suzuki H, Makita Y et al. Diagnosis and activity assessment of immunoglobulin A nephropathy: current perspectives on noninvasive testing with aberrantly glycosylated immunoglobulin A-related biomarkers. Int J Nephrol Renovasc Dis 2014; 7: 409-414
25. Moore JS, Kulhavy R, TomanaMet al. Reactivities of N-acetylgalactosaminespecific lectins with human IgA1 proteins. Mol Immunol 2007; 44: 2598-2604
26. Gomes MM, Suzuki H, Brooks MTet al. Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study. Biochemistry 2010; 49: 5671-5682